By Dina Inverso
March 15, 2017
Managing the cost of prescription drugs is a major economic challenge. As a result, prior authorization requirements are more demanding than ever. And, for doctors and patients, navigating the maze of regulations and restrictions can be frustrating at best. At worst, patient access to lifesaving therapies sometimes hangs in the balance.
A paradigm shift is required for people with rare medical conditions who require chronic care with medicines that are life-sustaining. This is a cost for life, and payers should focus on lifetime management cost. But instead, from the reimbursement coverage perspective, the process has become more granular and we are seeing more and more hurdles being created.
At CSL Behring, a Job Isn’t Just a Job
(Photo by Patrick Fore)
By Elizabeth Walker
December 14, 2016
I’m often asked, “What makes CSL Behring a great place to work?” For me, it’s about our patient centricity and company purpose. We develop and deliver innovative specialty biotherapies, helping people with life-threatening conditions live full lives. That’s an inspiring responsibility. Our CEO Paul Perreault encourages us to work each day as if people’s lives depend on us ‒ because they do. I can’t think of a better reason for coming to work every day.
If we focus on innovation and sustainability, healthcare will evolve in ways that are in sync with the changing needs of patients, the economy and global politics.
The following post is excerpted from Paul Perreault’s remarks at International BioFest 2016 in Melbourne, Australia.
December 6, 2016
Healthcare statisticians tell us that the first person who will live to 150 years of age has already been born. Considering human biology and the challenges we would need to overcome, doubling our life expectancy at first seems fanciful. But with our understanding of science and the refined art of personalized medicine, 150 may be reasonable.
In fact, our understanding of human biology is expanding at an exponential rate. Ten years ago it took the world’s greatest minds 10 years to map the human genome. Now it takes one day. Even for those of us in the healthcare sector, it is virtually impossible to predict what healthcare will look like in 50 or 100 years. But there are constants to guide us.
April 25, 2016
By Paul Perreault
Today we proudly mark CSL’s 100th anniversary, a milestone that is a testament to our values, science, people, and the patients we serve. For the past 100 years our vision, focus and agility have remained steadfast, enabling us to accomplish this feat. We have a rich heritage with an even brighter future. In many ways, we’re just getting started.
As a tangible expression of our values in action, and as a way of celebrating the CSL Centenary, we are establishing a $25 million R&D Fellowship program for early stage and translational research. The R&D Fellowship reflects the promise we made a century ago to save lives and protect people’s health.
June 11, 2015
By Patrick Castauro
Image of earth courtesy of NASA National Space Science Data Center
It wasn’t long ago that reporting on a company’s sustainability strategy, initiatives and performance was hardly a common practice. Today, disclosure in these performance areas is a mainstream activity. In fact, in many countries, the disclosure of economic, environmental and social sustainability is now required by law or mandated by securities exchanges.
As examples, Denmark, France, India, Indonesia, Japan, Malaysia, Norway, Singapore, South Africa, UK and the USA all have regimes in place for some kind of sustainability/corporate responsibility reporting. In Denmark, large companies are required to report on corporate responsibility activities and if they fail to do so, they must explain why not.